Latest News Archive

Please select Category, Year, and then Month to display items

RSVP

Please Click Here To RSVP

RSVP

Please Click Here To RSVP

UFS hosts national Indigenous Knowledge and Bio-Trade Indaba

23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event.

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.

News Archive

Doctors make history with unique heart operation

2012-04-04

Cardiologists at the university delivered the first Melody pulmonary valve in Africa.
Photo: Evert Kleynhans
30 March 2012

Academics of the Faculty of Health Sciences at the University of the Free State made history in Africa once again this week with the implant of a special pulmonary heart valve.

“Today we are extremely proud Free State citizens,” Prof. Stephen Brown and Dr. Danie Buys from the UFS Department of Paediatrics and Child Health said after they placed the Medtronic Melody pulmonary valve in two young patients at the Universitas hospital in Bloemfontein.

This is the first time in Africa that the Melody valve is placed.

To date there are currently only 3 000 of these valves place in the world.

“It feels incredible to be part of a team of experts from the faculty.”

The Medtronic Melody valve is delivered percutaneously through a catheter from the groin. This operation is for children and young adults who are born with a malformation of their pulmonary valve.

These children often require open-heart surgery at a very young age and later require additional open-heart surgeries to restore blood flow between the heart and the lungs.

Prof. Brown said that of all congenital diseases, heart disease is most common. A lot of children born with heart disease are diagnosed very late and many die without ever receiving specialised care.

In 2011, Prof. Brown and two other cardiologists from the UFS, Prof. Hennie Theron en Dr JP Theron also reached a medical milestone when they were the first cardiologists in South Africa to do a second generation Medtronic CoreValve implant on an elderly patient.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept